Trial intelligence / Profile preview

Oral oxycodone vs oral meloxicam for pre-emptive postoperative pain control after adult tonsillectomy

IRCT20230926059532N1Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Tonsillar hyperplasia and postoperative pain comparing Oral oxycodone pre-emptive analgesia with Oral meloxicam pre-emptive analgesia (2 arms). Primary endpoint: Postoperative pain intensity. Started Oct 2023; status: completed.

02

Drugs

oxycodonemeloxicam
03

Conditions

Tonsillar hyperplasiapostoperative pain

Beyond the preview

Go deeper on IRCT20230926059532N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230926059532N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call